GO:0003872 6-phosphofructokinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003872 defines the molecular function that catalyzes ATP + D-fructose-6-phosphate = ADP + D-fructose 1,6-bisphosphate, a committed step of glycolysis.
• The reaction is strongly regulated by fructose 2,6-bisphosphate, which activates 6-phosphofructokinase and helps control glycolytic flux.
• 6-phosphofructokinase activity can be assayed in human muscle using fructose-2,6-diphosphate to stimulate the reaction.
• In some organisms, the 6-phosphofructokinase reaction can use pyrophosphate as an alternative phosphate donor, expanding its biochemical diversity.
• The enzyme participates in temporal organization and irreversible transitions of the phosphofructokinase/fructose-1,6-bisphosphatase cycle.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of 6-phosphofructokinase genes in metabolism and disease.
Description
6-phosphofructokinase activity (GO:0003872) is a molecular function that catalyzes the phosphorylation of D-fructose-6-phosphate to D-fructose 1,6-bisphosphate using ATP as the phosphate donor. This reaction is a key control point in glycolysis, and its regulation determines how rapidly glucose is consumed by cells. Because the reaction is essentially irreversible under physiological conditions, it helps set the direction of carbon flow through the phosphofructokinase/fructose-1,6-bisphosphatase cycle. Researchers study this activity to understand metabolic regulation, energy homeostasis, and how glycolytic flux is adjusted in normal and diseased tissues. The activity is modulated by fructose 2,6-bisphosphate and other effectors, making it a sensitive node for metabolic control. In human muscle, the activity can be measured with assays that use fructose-2,6-diphosphate to stimulate the enzyme. Comparative studies have also shown that in some bacteria the 6-phosphofructokinase reaction can be both ATP- and pyrophosphate-dependent, highlighting evolutionary variation in this function.
6-phosphofructokinase activity At A Glance
| GO ID | GO:0003872 |
|---|---|
| GO term | 6-phosphofructokinase activity |
| Ontology | molecular_function |
| Definition | Catalysis of the reaction: ATP + D-fructose-6-phosphate = ADP + D-fructose 1,6-bisphosphate. |
| Synonym | ATP-dependent phosphofructokinase activity; fructose 6-phosphate kinase activity; phosphofructokinase I activity; phosphohexokinase activity |
| Major function | Phosphorylation of D-fructose-6-phosphate to D-fructose 1,6-bisphosphate in glycolysis |
| Cofactors/effectors | ATP as phosphate donor; fructose 2,6-bisphosphate and 6-phosphogluconate as activators |
| Pathway context | Glycolysis and the phosphofructokinase/fructose-1,6-bisphosphatase cycle |
| Assay note | Activity can be measured in human muscle using fructose-2,6-diphosphate |
What Is GO:0003872?
In simple terms, 6-phosphofructokinase activity is the enzyme function that adds a phosphate group to fructose-6-phosphate, producing fructose 1,6-bisphosphate and consuming ATP. The official definition is: Catalysis of the reaction: ATP + D-fructose-6-phosphate = ADP + D-fructose 1,6-bisphosphate. This activity is synonymous with phosphofructokinase I, ATP-dependent phosphofructokinase, and fructose 6-phosphate kinase, among other names. It is a molecular_function term in the Gene Ontology and represents the committed step of glycolysis.
Why Is 6-phosphofructokinase activity Important in Cell Biology?
6-phosphofructokinase activity is important because it controls the rate-limiting step of glycolysis, and its regulation directly influences ATP production, biosynthetic precursor supply, and metabolic adaptation. Fructose 2,6-bisphosphate is a potent activator that links this activity to hormonal and nutritional signals. The reaction also participates in the temporal organization of the phosphofructokinase/fructose-1,6-bisphosphatase cycle, which helps prevent futile cycling. Because the activity is essentially irreversible, it is a key determinant of glycolytic directionality. In human muscle, reliable assays for this activity are needed to study metabolic myopathies and exercise physiology. In bacteria, the discovery of ATP- and pyrophosphate-dependent 6-phosphofructokinase reactions shows that this function can adapt to different energy economies.
• Controls the committed and rate-limiting step of glycolysis.
• Regulated by fructose 2,6-bisphosphate, a key glycolytic activator.
• Participates in the phosphofructokinase/fructose-1,6-bisphosphatase cycle that prevents futile cycling.
• Provides a measurable biochemical activity in human muscle for clinical and exercise studies.
• Shows evolutionary flexibility, including pyrophosphate-dependent forms in some bacteria.
• Is a target for understanding metabolic reprogramming in cancer and other diseases.
• Can be studied with CRISPR knockout, point mutation, knock-in, and overexpression models.
• Serves as a node for integrating hormonal and nutritional signals via fructose 2,6-bisphosphate.
• Its irreversible nature helps set glycolytic directionality.
• Assays using fructose-2,6-diphosphate improve detection in muscle samples.
Molecular Mechanism of 6-phosphofructokinase activity
Substrate binding and phosphoryl transfer
In simple terms: The enzyme grabs fructose-6-phosphate and ATP, then transfers a phosphate from ATP onto the sugar.
6-phosphofructokinase activity catalyzes the transfer of a phosphoryl group from ATP to D-fructose-6-phosphate, yielding ADP and D-fructose 1,6-bisphosphate. This reaction is the committed step of glycolysis and is essentially irreversible under physiological conditions. The enzyme requires ATP as the phosphate donor, and the reaction is part of the phosphofructokinase/fructose-1,6-bisphosphatase cycle that organizes glycolytic and gluconeogenic flux.
Allosteric activation by fructose 2,6-bisphosphate
In simple terms: A small molecule called fructose 2,6-bisphosphate acts like a gas pedal, making the enzyme work faster.
Fructose 2,6-bisphosphate strongly stimulates 6-phosphofructokinase activity in yeast and liver. In rat tissues, both 6-phosphogluconate and fructose 2,6-bisphosphate activate the enzyme, linking glycolytic flux to other metabolic signals. This allosteric regulation allows the activity to respond rapidly to hormonal and nutritional changes.
Assay and detection in human muscle
In simple terms: Scientists can measure this enzyme in muscle samples by adding fructose-2,6-diphosphate to boost the signal.
A clinical assay for 6-phosphofructokinase activity in human muscle uses fructose-2,6-diphosphate to stimulate the reaction, improving detection. This method is useful for studying metabolic myopathies and for validating enzyme activity in patient biopsies. The assay relies on the same catalytic reaction defined by GO:0003872.
Alternative phosphate donors and evolutionary variation
In simple terms: Some bacteria can run this reaction using pyrophosphate instead of ATP, showing the enzyme is flexible.
In Acetivibrio thermocellus, the 6-phosphofructokinase reaction is both ATP- and pyrophosphate-dependent, demonstrating that the activity can use different phosphate donors. This finding expands the biochemical definition of the reaction beyond the canonical ATP-dependent form. Such variation is important for understanding microbial metabolism and for biotechnological applications.
Temporal organization and irreversible transitions
In simple terms: The enzyme works in a cycle with its opposing enzyme, and the cycle can switch direction in a coordinated way.
The phosphofructokinase/fructose-1,6-bisphosphatase cycle shows temporal organization that helps coordinate glycolysis and gluconeogenesis. Irreversible transitions in this cycle have been described, meaning the system can flip between states in a switch-like manner. These properties are central to how 6-phosphofructokinase activity contributes to metabolic control.
Key Genes Involved in GO:0003872 6-phosphofructokinase activity
The following genes and proteins are directly or indirectly associated with 6-phosphofructokinase activity, based on the verified literature and standard gene nomenclature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PFKL | Liver-type 6-phosphofructokinase | Studied for liver glycolytic regulation and fructose 2,6-bisphosphate response |
| PFKM | Muscle-type 6-phosphofructokinase | Assayed in human muscle; linked to glycolytic myopathies |
| PFKP | Platelet-type 6-phosphofructokinase | Investigated in cancer metabolism and glycolytic flux |
| PFKFB1 | Fructose-2,6-bisphosphatase/kinase | Regulates fructose 2,6-bisphosphate levels that activate PFK |
| PFKFB2 | Fructose-2,6-bisphosphatase/kinase | Modulates PFK activity in response to hormones |
| PFKFB3 | Fructose-2,6-bisphosphatase/kinase | Controls glycolytic flux in proliferating cells |
| PFKFB4 | Fructose-2,6-bisphosphatase/kinase | Regulates PFK in cancer and stress responses |
| FBP1 | Fructose-1,6-bisphosphatase | Opposes PFK in the PFK/FBP cycle |
| FBP2 | Fructose-1,6-bisphosphatase | Participates in the PFK/FBP cycle in muscle |
| ATP | Phosphate donor | Required substrate for the reaction |
| D-fructose-6-phosphate | Substrate | Converted to D-fructose 1,6-bisphosphate |
| D-fructose 1,6-bisphosphate | Product | Glycolytic intermediate |
| Fructose 2,6-bisphosphate | Allosteric activator | Stimulates PFK activity |
| 6-phosphogluconate | Allosteric activator | Activates PFK from rat tissues |
| Actin | Cytoskeletal protein | Copurifies with phosphofructokinase |
| Pyrophosphate | Alternative phosphate donor | Used by some bacterial PFKs |
| ADP | Product | Produced alongside fructose 1,6-bisphosphate |
How Is 6-phosphofructokinase activity Regulated?
6-phosphofructokinase activity is regulated by allosteric effectors, especially fructose 2,6-bisphosphate, which activates the enzyme in yeast and liver. In rat tissues, 6-phosphogluconate also activates the enzyme, linking it to the pentose phosphate pathway. The activity is embedded in the phosphofructokinase/fructose-1,6-bisphosphatase cycle, which shows temporal organization and irreversible transitions that help coordinate glycolysis and gluconeogenesis. These regulatory features allow the enzyme to respond to hormonal and nutritional signals and to maintain metabolic homeostasis.
6-phosphofructokinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PFKM | Muscle glycogenosis / glycolytic myopathy | PFKM knockout or point-mutation muscle cells |
| PFKL | Liver metabolic disorders | PFKL knockout hepatocytes |
| PFKP | Cancer metabolism | PFKP overexpression in cancer cell lines |
| PFKFB3 | Proliferative disorders | PFKFB3 knockout or knock-in models |
| FBP1 | Hypoglycemia / metabolic stress | FBP1 knockout liver cells |
Metabolic myopathies and muscle disorders
Defects in 6-phosphofructokinase activity can impair muscle glycolysis, and assays using fructose-2,6-diphosphate are used to measure the enzyme in human muscle biopsies. Such measurements help diagnose metabolic myopathies and understand exercise intolerance. The regulation of the enzyme by fructose 2,6-bisphosphate is also relevant to muscle energy metabolism.
Cancer metabolism
Cancer cells often rely on high glycolytic flux, and 6-phosphofructokinase activity is a key control point. Fructose 2,6-bisphosphate, which activates the enzyme, is often elevated in proliferating cells. Targeting this activity is an area of interest for metabolic anticancer strategies.
Liver and systemic metabolic regulation
In liver, 6-phosphofructokinase activity is controlled by fructose 2,6-bisphosphate and other effectors, influencing whole-body glucose homeostasis. Dysregulation of this activity may contribute to metabolic disorders such as diabetes and fatty liver disease. Studying the enzyme in liver models helps clarify these connections.
From 6-phosphofructokinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PFKM reduce glycolytic flux? | PFKM knockout cell line |
| Does a point mutation alter allosteric activation by fructose 2,6-bisphosphate? | PFKM point-mutation knock-in |
| Can tagged PFK be used for localization studies? | Tagged knock-in of PFKL |
| Does PFKP overexpression increase lactate production? | PFKP overexpression cell model |
| Which genes modify PFK activity? | CRISPR library screening |
| What is the metabolic signature of PFK loss? | Metabolomics and RNA-seq of knockout cells |
How to Study the 6-phosphofructokinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay with fructose-2,6-diphosphate | 6-phosphofructokinase activity | Human muscle biopsies |
| Metabolomics | Glycolytic intermediates | Knockout cell lines |
| 13C flux analysis | Glycolytic flux | Cancer metabolism studies |
| CRISPR knockout screening | Gene essentiality and modifiers | Metabolic vulnerability discovery |
| Western blot | Protein expression | Validation of knockout or overexpression |
| Immunofluorescence | Subcellular localization | Tagged knock-in cells |
| Co-immunoprecipitation | Protein interactions | Actin-PFK interaction studies |
| RNA-seq | Transcriptional changes | Pathway analysis after PFK perturbation |
Enzymatic activity assays
6-phosphofructokinase activity can be measured spectrophotometrically by coupling the reaction to NADH oxidation or by using fructose-2,6-diphosphate to stimulate the enzyme in human muscle samples. These assays are essential for validating enzyme function in cells and tissues.
Metabolomics and flux analysis
Metabolomics can quantify fructose-6-phosphate, fructose 1,6-bisphosphate, and other glycolytic intermediates to infer 6-phosphofructokinase activity in cells. Flux analysis using labeled glucose helps determine how the reaction contributes to overall glycolytic flux.
CRISPR screening and functional genomics
CRISPR knockout libraries can identify genes that modify 6-phosphofructokinase activity or glycolytic dependence. Such screens are useful for discovering synthetic lethal interactions and metabolic vulnerabilities.
Protein interaction and localization studies
Actin-severing activity copurifies with phosphofructokinase, suggesting interactions with the cytoskeleton. Tagged knock-in models and imaging can reveal where the enzyme localizes and how it interacts with other proteins.
How CRISPR Can Be Used to Study GO:0003872 6-phosphofructokinase activity
Knockout
CRISPR knockout of PFK genes can abolish 6-phosphofructokinase activity, allowing researchers to test its role in glycolysis and cell growth. Knockout models are useful for identifying compensatory pathways and metabolic dependencies.
Point Mutation
Point mutations can be introduced into PFK genes to dissect allosteric regulation by fructose 2,6-bisphosphate or catalytic residues. Such models help distinguish between catalytic and regulatory functions.
Knock-in
Knock-in of tagged PFK alleles enables localization and interaction studies without altering endogenous regulation. This approach is valuable for understanding how PFK interacts with actin and other cellular structures.
Overexpression
Overexpression of PFK genes can increase glycolytic flux and lactate production, modeling cancer-like metabolism. These models are used to test whether elevated 6-phosphofructokinase activity drives proliferation or stress resistance.
How EDITGENE Supports 6-phosphofructokinase activity Research
Researchers studying 6-phosphofructokinase activity-related genes often need to determine whether a candidate gene is causally involved in glycolytic regulation, metabolic disease, or cancer. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for 6-phosphofructokinase activity research.
Frequently Asked Questions About 6-phosphofructokinase activity
What is 6-phosphofructokinase activity?
It is the enzyme function that catalyzes ATP + D-fructose-6-phosphate = ADP + D-fructose 1,6-bisphosphate, a key step in glycolysis.
What genes are involved in 6-phosphofructokinase activity?
Genes include PFKL, PFKM, PFKP, and the PFKFB family that regulates fructose 2,6-bisphosphate levels.
How is 6-phosphofructokinase activity regulated?
It is activated by fructose 2,6-bisphosphate and 6-phosphogluconate, and participates in the PFK/FBP cycle.
How can I measure 6-phosphofructokinase activity?
Enzymatic assays using fructose-2,6-diphosphate can measure activity in human muscle and other samples.
What is the role of fructose 2,6-bisphosphate in PFK activity?
It is a potent allosteric activator that stimulates 6-phosphofructokinase activity in yeast and liver.
Is 6-phosphofructokinase activity involved in cancer?
Yes, it is a control point for glycolytic flux in cancer cells and is studied as a metabolic target.
Can 6-phosphofructokinase use pyrophosphate instead of ATP?
In some bacteria such as Acetivibrio thermocellus, the reaction can be both ATP- and pyrophosphate-dependent.
What is the PFK/FBP cycle?
It is the cycle between phosphofructokinase and fructose-1,6-bisphosphatase that helps coordinate glycolysis and gluconeogenesis.
Does phosphofructokinase interact with actin?
Actin-severing activity has been found to copurify with phosphofructokinase, suggesting an interaction.
How can CRISPR help study 6-phosphofructokinase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of PFK genes in metabolism and disease.
Conclusion
6-phosphofructokinase activity (GO:0003872) is a central molecular function in glycolysis, catalyzing the conversion of D-fructose-6-phosphate to D-fructose 1,6-bisphosphate. Its regulation by fructose 2,6-bisphosphate and other effectors makes it a key node for metabolic control. Studying this activity with enzymatic assays, metabolomics, and CRISPR models can reveal how glycolytic flux is altered in disease. Continued research will clarify its roles in cancer, muscle disorders, and microbial metabolism.
References
- 1. Avigad G. 1981. Stimulation of yeast phosphofructokinase activity by fructose 2,6-bisphosphate.. Biochem Biophys Res Commun 102(3):985-91 PMID: 6458303
- 2. Schliselfeld LH et al.. 1996. Use of fructose-2,6-diphosphate to assay for phosphofructokinase activity in human muscle.. Clin Biochem 29(1):79-83 PMID: 8929829
- 3. Van Schaftingen E et al.. 1981. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors.. Proc Natl Acad Sci U S A 78(6):3483-6 PMID: 6455662
- 4. Füchtbauer A et al.. 1986. Actin-severing activity copurifies with phosphofructokinase.. Proc Natl Acad Sci U S A 83(24):9502-6 PMID: 3025844
- 5. Hofmann E et al.. 1985. Temporal organization of the phosphofructokinase/fructose-1,6-biphosphatase cycle.. Adv Enzyme Regul 23:331-62 PMID: 3000145
- 6. Koendjbiharie JG et al.. 2024. The 6-phosphofructokinase reaction in Acetivibrio thermocellus is both ATP- and pyrophosphate-dependent.. Metab Eng 86:41-54 PMID: 39245400
- 7. Schellenberger W et al.. 1991. Irreversible transitions in the 6-phosphofructokinase/fructose 1,6-bisphosphatase cycle.. Eur J Biochem 195(1):109-13 PMID: 1846809
- 8. Sommercorn J et al.. 1984. Activation of phosphofructokinase from rat tissues by 6-phosphogluconate and fructose 2,6-bisphosphate.. Arch Biochem Biophys 232(2):579-84 PMID: 6235777
